The study identified 161 unique pathological combinations, with the most frequent scenario in AD patients being the co-occurrence of Aβ, tau, cerebral amyloid angiopathy (CAA), and TDP-43 [59]. This evidence concerns the gene MAPT and Alzheimer disease.